← Leaderboards
Esteban Celis
Mayo Clinic Coll Of Medicine, Rochester
$7,550,811
Attributed
$7,550,811
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $684.7K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$7,550,811 · 6
By mechanism
R01$7,550,811 · 5
P50$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Karl A. Nath$16,198,966
Others in their field
Top investigators on “Tumor Antigens”
- William R Green · Dartmouth College$32,738,211
- John H Sampson · Duke University$30,849,602
- Catherine Ju-Ying Wu · Broad Institute, Inc.$30,485,072
- Elizabeth Marion Jaffee · Johns Hopkins University$26,862,085
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$24,066,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
Research focus
Tumor AntigensSynthetic PeptideCytotoxic T LymphocyteNeoplasm /Cancer ImmunotherapyHelper T LymphocyteImmune ResponseNeoplastic CellT-LymphocyteTumor GrowthEpitopesVaccinesVaccinationImmuneTumorMalignant NeoplasmsClinicDesignToll-Like ReceptorsResponseImmune SystemImmunizationPeptide VaccinesResearch StudyIn Vivo
Grant awards (34)
Interferon-gamma limits the effectiveness of peptide vaccines for cancer$294,616
R01 · FY2017 · CA · contact PI
Interferon-gamma limits the effectiveness of peptide vaccines for cancer$20,784
R01 · FY2016 · CA · contact PI
Interferon-gamma limits the effectiveness of peptide vaccines for cancer$314,363
R01 · FY2015 · CA · contact PI
Interferon-gamma limits the effectiveness of peptide vaccines for cancer$302,919
R01 · FY2014 · CA · contact PI
Interferon-gamma limits the effectiveness of peptide vaccines for cancer$328,659
R01 · FY2013 · CA · contact PI
Treatment of Melanoma with Optimzed Peptide Vaccines$258,324
R01 · FY2013 · CA · contact PI
Treatment of Melanoma with Optimzed Peptide Vaccines$57,638
R01 · FY2013 · CA · contact PI
Interferon-gamma limits the effectiveness of peptide vaccines for cancer$348,600
R01 · FY2012 · CA · contact PI
Treatment of Melanoma with Optimzed Peptide Vaccines$336,129
R01 · FY2012 · CA · contact PI
Treatment of Melanoma with Optimzed Peptide Vaccines$336,129
R01 · FY2011 · CA · contact PI
Treatment of Melanoma with Optimzed Peptide Vaccines$346,525
R01 · FY2010 · CA · contact PI
Treatment of Melanoma with Optimzed Peptide Vaccines$346,352
R01 · FY2009 · CA · contact PI
Optimization of Peptide Based Vaccines for Cancer$258,392
R01 · FY2008 · CA · contact PI
Trojan Antigens: A Multiple-Epitope Vaccine for Cancer$312,971
R01 · FY2007 · CA · contact PI
Optimization of Peptide Based Vaccines for Cancer$253,468
R01 · FY2007 · CA · contact PI
Trojan Antigens: A Multiple-Epitope Vaccine for Cancer$322,318
R01 · FY2006 · CA · contact PI
Optimization of Peptide Based Vaccines for Cancer$261,038
R01 · FY2006 · CA · contact PI
Trojan Antigens: A Multiple-Epitope Vaccine for Cancer$97,800
R01 · FY2006 · CA · contact PI
Trojan Antigens: A Multiple-Epitope Vaccine for Cancer$289,575
R01 · FY2005 · CA
Optimization of Peptide Based Vaccines for Cancer$208,518
R01 · FY2005 · CA
Optimization of Peptide Based Vaccines for Cancer$25,729
R01 · FY2005 · CA
Trojan Antigens: A Multiple-Epitope Vaccine for Cancer$298,688
R01 · FY2004 · CA
Optimization of Peptide Based Vaccines for Cancer$203,456
R01 · FY2004 · CA
Optimization of Peptide Based Vaccines for Cancer$38,444
R01 · FY2004 · CA
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS$317,121
R01 · FY2003 · CA
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS$309,716
R01 · FY2002 · CA
IMMUNE BASED THERAPEUTIC APPROACH FOR PROSTATE CANCER$0
P50 · FY2002 · CA
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS$302,526
R01 · FY2001 · CA
IMMUNE BASED THERAPEUTIC APPROACH FOR PROSTATE CANCER$204,507
R01 · FY2001 · CA
IMMUNE BASED THERAPEUTIC APPROACH FOR PROSTATE CANCER$30,277
R01 · FY2001 · CA
IMMUNE BASED THERAPEUTIC APPROACH FOR PROSTATE CANCER$0
P50 · FY2001 · CA
EPITOPE BASED T CELL THERAPY FOR EPITHELIAL TUMORS$295,544
R01 · FY2000 · CA
IMMUNE BASED THERAPEUTIC APPROACH FOR PROSTATE CANCER$200,290
R01 · FY2000 · CA
IMMUNE BASED THERAPEUTIC APPROACH FOR PROSTATE CANCER$29,395
R01 · FY2000 · CA